Desferrioxamine, an iron chelator, inhibits CXCL10 expression induced by polyinosinic-polycytidylic acid in U373MG human astrocytoma cells

Neuroscience Research

Volumn 94, Issue , 2015, Pages 10-16

  Imaizumi, Tadaatsu ^a   Sakashita, Nina ^a   Mushiga, Yasuaki ^a   Yoshida, Hidemi ^a   Hayakari, Ryo ^a   Xing, Fei ^a   Wang, Liang ^a   Matsumiya, Tomoh ^a   Tanji, Kunikazu ^a   Chiba, Yuki ^b   Furudate, Ken ^a   Kawaguchi, Shogo ^a   Murakami, Manabu ^b   Tanaka, Hiroshi ^b  

^a HIROSAKI UNIVERSITY   (Japan)

^b HIROSAKI UNIVERSITY   (Japan)

Author keywords

CXCL10; DFX; FeSO4; STAT1; TLR3; U373MG cells

Indexed keywords

BETA INTERFERON; DEFEROXAMINE; GAMMA INTERFERON INDUCIBLE PROTEIN 10; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; HYPOXIA INDUCIBLE FACTOR 1ALPHA; INTERFERON INDUCED PROTEIN WITH TETRATRICOPEPTIDE REPEAT 1; INTERFERON INDUCED PROTEIN WITH TETRATRICOPEPTIDE REPEAT 2; IRON; MELANOMA DIFFERENTIATION ASSOCIATED GENE 5; POLYINOSINIC POLYCYTIDYLIC ACID; PROTEIN; RETINOIC ACID INDUCIBLE PROTEIN I; STAT1 PROTEIN; TOLL LIKE RECEPTOR 3; UNCLASSIFIED DRUG; VASCULOTROPIN; CXCL10 PROTEIN, HUMAN; INTERFERON INDUCING AGENT; IRON CHELATING AGENT; MESSENGER RNA; SMALL INTERFERING RNA; STAT1 PROTEIN, HUMAN; VASCULOTROPIN A;

ARTICLE; ASTROCYTOMA CELL; CONTROLLED STUDY; DRUG MECHANISM; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; IN VITRO STUDY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; REAL TIME POLYMERASE CHAIN REACTION; RNA INTERFERENCE; WESTERN BLOTTING; ASTROCYTOMA; DOSE RESPONSE; DRUG EFFECTS; DRUG INTERACTION; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; PATHOLOGY; SIGNAL TRANSDUCTION; TUMOR CELL LINE;

ASTROCYTOMA; CELL LINE, TUMOR; CHEMOKINE CXCL10; DEFEROXAMINE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; ENZYME-LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INTERFERON INDUCERS; IRON CHELATING AGENTS; POLY I-C; RNA, MESSENGER; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; STAT1 TRANSCRIPTION FACTOR; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84927909523     PISSN: 01680102     EISSN: 18728111     Source Type: Journal    
DOI: 10.1016/j.neures.2015.01.001     Document Type: Article

References (34)

1. Andersen H.H., Johnsen K.B., Moos T. Iron deposits in the chronically inflamed central nervous system and contributes to neurodegeneration. Cell Mol. Life Sci. 2014, 71:1607-1622.
2. Balashov K.E., Rottman J.B., Weiner H.L., Hancock W.W. CCR5(+) and CXCR3(+) T cells are increased in multiple sclerosis and their ligands MIP-1α and IP-10 are expressed in demyelinating lesions. Proc. Natl. Acad Sci. U.S.A. 1999, 96:6873-6878.
3. Brierley M.N., Fish E.N. Stats: multifaceted regulators of transcription. J. Interferon Cytokine Res. 2005, 25:733-744.
4. Crichton R.R., Dexter D.T., Ward R.J. Brain iron metabolism and its perturbation in neurological diseases. J. Neuronal. Transm. 2011, 118:301-314.
5. Chu P.W.Y., Beart P.M., Jones N.M. Preconditioning protects against oxidative injury involving hypoxia-inducible factor-1 and vascular endothelial growth factor in cultured astrocytes. Eur. J. Pharmacol. 2010, 633:24-32.
6. Choi E.Y., Park Z.Y., Choi E.J., Oh H.M., Lee S., Choi S.C., Lee K.M., Im S.H., Chun J.S., Jun C.D. Transcriptional regulation of IL-8 by iron chelator in human epithelial cells is independent from NF-κB but involves ERK1/2- and p38 kinase-dependent activation of AP-1. J. Cell. Biochem. 2007, 102:1442-1457.
7. Farina C., Aloisi F., Meinl E. Astrocytes are active players in cerebral innate immunity. Trends Immunol. 2007, 28:138-145.
8. Fensterl V., Sen G.C. The ISG56/IFIT1 gene family. J. Interferon Cytokine Res. 2011, 31:71-77.
9. Fensterl V., Wetzel J.L., Ramachandran S., Ogino T., Stohlman S.A., Bergmann C.C., Diamond M.S., Virgin H.W., Sen G.C. Interferon-induced Ifit2/ISG54 protects mice from lethal VSV neuropathogenesis. PLoS. Pathogens 2012, 8:e1002712.
10. Galimberti D., Schoonenboom N., Scheltens P., Fenoglio C., Bouwman F., Venturelli E., Gruol I., Blamkenstein M.A., Bresolin N., Scarpini E. Intrathecal chemokine synthesis in mild cognitive impairment and Alzheimer's disease. Arch. Neurol. 2006, 63:538-543.
11. Gira A.K., Kowalczyk A.P., Feng Y., Swerlick R.A. Iron chelators and hypoxia mimetics inhibit IFN-γ-mediated Jak-STAT signaling. J. Invest. Dermatol. 2009, 129:723-729.
12. Imaizumi T., Aratani S., Nakajima T., Carlson M., Matsumiya T., Tanji K., Ookawa K., Yoshida H., Tsuchida S., McIntyre T.M., Prescott S.M., Zimmerman G.A., Satoh K. Retinoic acid-inducible gene-I (RIG-I) is induced in endothelial cells by LPS and regulates expression of COX-2. Biochem. Biophys. Res. Commun. 2002, 292:274-279.
13. Imaizumi T., Murakami K., Ohta K., Seki H., Matsumiya T., Meng P., Hayakari R., Xing F., Aizawa-Yashiro T., Tatsuta T., Yoshida H., Kijima H. MDA5 and ISG56 mediate CXCL10 expression induced by Toll-like receptor 4 activation in U373MG human astrocytoma cells. Neurosci. Res. 2013, 76:195-206.
14. Imaizumi T., Numata A., Yano C., Yoshida H., Hayakari R., Xing F., Wang L., Matsumiya T., Tanji K., Murakami M., Tanaka H. ISG54 and ISG56 are induced by TLR3 signaling in U373MG human astrocytoma cells: possible involvement in CXCL10 expression. Neurosci. Res. 2014, 84:34-42.
15. Kang D.C., Gopalkrishnan R.V., Wu Q., Jankowsky E., Pyle A.M., Fisher P.B. Mda-5: an interferon-inducible putative RNA helicase with double-stranded RNA-dependent ATPase activity and melanoma growth-suppressive properties. Proc. Natl. Acad. Sci. U.S.A. 2002, 99:637-642.
16. Kigerl K.A., Popvich P.G. Toll-like receptors in spinal cord injury. Curr. Top. Microbiol. Immunol. 2009, 336:121-136.
17. Koo S.W., Casper K.A., Otto K.B., Gira A.K., Swerlick R.A. Iron chelators inhibit VCAM-1 expression in human dermal microvascular endothelial cells. J. Invest. Dermatol. 2003, 120:871-879.
18. Mehla R., Mehla S.B., Nagarkatti M., Chauhan A. Programming of neurotoxic cofactor CXCL10 in HIV-1-associated dementia: abrogation of CXCL10-induced neuro-glial toxicity in vitro by PKC activator. J. Neuroinflamm. 2012, 9:239.
19. Muller M., Carter S., Hofer M.J., Campbell I.L. The chemokine receptor CXCR3 and its ligands CXCL9 CXCL10 and CXCL11 in neuroimmunity - a tale of conflict and conundrum. Neuropathol. Appl. Neurobiol. 2010, 36:368-387.
20. Percy M.E., Kruck T.P.A., Pogue A.I., Lukiw W.J. Towards the prevention of potential aluminum toxic effects and an effective treatment for Alzheimer's disease. J. Inorg. Biochem. 2011, 105:1505-1512.
21. Rappert A., Bechmann I., Pivneva T., Mahlo J., Biber K., Nolte C., Kovac A.D., Gerard C., Boddeke H.W., Nitsch R., Kettenmann H. CXCR3-dependent microglial recruitment is essential for dendrite loss after brain lesion. J. Neurosci. 2004, 25:312-322.
22. Raven E.P., Lu P.H., Tishler T.A., Heydari P., Bartzokis G. Increased iron levels and decreased tissue integrity in hippocampus of Alzheimer's disease detected in vivo with magnetic resonance imaging. J. Alzheimers Dis. 2013, 37:127-136.
23. Schwer B. A new twist on RNA helicases: DExH/D box proteins as RNPases. Nat. Struct. Biol. 2001, 8:113-116.
24. Sofroniew M.V., Vinters H.V. Astrocytes: biology and pathology. Acta Neuropathol. 2010, 119:7-35.
25. Stankiewicz J.M., Neema M., Ceccarelli A. Iron and multiple sclerosis. Neurobiol. Aging 2014, 35:S51-S58.
26. Tanji K., Imaizumi T., Matsumiya T., Itaya H., Fujimoto K., Cui X., Toki T., Ito E., Yoshida H., Wakabayashi K., Satoh K. Desferrioxamine, an iron chelator, upregulates cyclooxygenase-2 expression and prostaglandin production in a human macrophage cell line. Biochim. Biophys. Acta 2001, 1530:227-235.
27. Varesio L., Battaglia F., Raggi F., Ledda B., Bosco M.C. Macrophage-inflammatory protein-3α/CCL20 is transcriptionally induced by the iron chelator desferrioxamine in human mononuclear phagocytes through nuclear factor (NF)-κB. Mol. Immunol. 2010, 47:685-693.
28. Weinreb O., Mandel S., Youdim M.B.H., Amit T. Targeting dysregulation of brain iron homeostasis in Parkinson's disease by iron chelators. Free Radic. Biol. Med. 2013, 62:52-64.
29. Yoneyama M., Kikuchi M., Matsumoto K., Imaizumi T., Miyagishi M., Taira K., Foy E., Loo Y.M., Gale M., Akira S., Yonehara S., Kato A., Fujita T. Shared and unique functions of the DExD/H-box helicases RIG-I MDA5 and LGP2 in antiviral innate immunity. J. Immunol. 2005, 175:2851-2858.
30. Yoshida H., Imaizumi T., Tanji K., Matsumiya T., Sakaki H., Kimura D., Cui X.F., Kumagai M., Tamo W., Shibata T., Hatakeyama M., Sato Y., Satoh K. Platelet-activating factor enhances the expression of vascular endothelial growth factor in normal human astrocytes. Brain Res. 2002, 944:65-72.
31. Yoshida H., Imaizumi T., Lee S.J., Tanji K., Sakaki H., Matsumiya T., Ishikawa A., Taima K., Yuzawa E., Mori F., Wakabayashi K., Kimura H., Satoh K. Retinoic acid-inducible gene-I mediates RANTES/CCL5 expression in U373MG human astrocytoma cells stimulated with double-stranded RNA. Neurosci. Res. 2007, 58:199-206.
32. Zhang W.J., Wei H., Frei B. The iron chelator, desferrioxamine, reduces inflammation and atherosclerotic lesion development in experimental mice. Exp. Biol. Med. 2010, 235:633-641.
33. Zhang Z., Zhang K., Du X., Li Y. Neuroprotection of desferrioxamine in lipopolysaccharide-induced nigrostriatal dopamine neuron degeneration. Mol. Med. Rep. 2012, 5:562-566.
34. Zhou X., Michal J.J., Zhang L., Ding B., Lunney J.K., Liu B., Jiang Z. Interferon induced IFIT family genes in host antiviral defense. Int. J. Biol. Sci. 2013, 9:200-208.